Precision medicine is rapidly transforming healthcare, and one of the most significant accelerators of its progress has been the dramatic reduction in cost. In this webinar, we explore how innovations in genomics and biotherapeutics are making advanced, personalized healthcare more accessible and affordable than ever before. Dr. George M. Church will examine how the cost of whole genome sequencing has been reduced from $3 billion per haploid genome—previously unusable in clinical settings—to just $300 per phased diploid genome today. We’ll also look at the economics behind cell therapy, such as blood transfusions (now as low as $200), and gene therapy technologies like mRNA vaccines (available for as little as $30).